Hostname: page-component-745bb68f8f-l4dxg Total loading time: 0 Render date: 2025-01-16T20:10:17.019Z Has data issue: false hasContentIssue false
  • English
  • Français

P-692 - Hyperprolactinaemia and Psychosis

Published online by Cambridge University Press:  15 April 2020

E.N. Rizos ,
E. Tsigaropoulou ,
M. Peppa ,
P. Ferentinos ,
C. Zompola  and
L. Lykouras
E.N. Rizos
Affiliation:
2nd Psychiatric Dpt, Athen, Greece
E. Tsigaropoulou
Affiliation:
2nd Psychiatric Dpt, Athen, Greece
M. Peppa
Affiliation:
University of Athen, Medical School, Athen, Greece
P. Ferentinos
Affiliation:
2nd Psychiatric Dpt, Athen, Greece
C. Zompola
Affiliation:
2nd Psychiatric Dpt, Athen, Greece
L. Lykouras
Affiliation:
2nd Psychiatric Dpt, Athen, Greece

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objective:

Hyperprolactinaemia causes hypogonadotropic hypogonadism. Hyperprolactinaemia could be pre-existing in some patients with schizophrenia. Dopamine is the most important prolactin inhibiting factor, while dopaminergic hyperactivity has been implicated to the pathophysiology of psychosis.

Method:

We present the case of a patient with hypogonadism secondary to chronic, untreated hyperprolactinaemia who developed acute psychotic symptoms.

Results:

Psychotic symptoms resolved soon after treatment with aripiprazole in conjunction with cabergoline, with a concomitant decrease in serum prolactin levels.

Conclusion:

An interesting cause effect relationship of hyperprolactinaemia and psychosis has been suggested

Type
Abstract
Information
European Psychiatry , Volume 27 , Issue S1: Abstracts of the 20th European Congress of Psychiatry , 2012 , pp. 1
Copyright
Copyright © European Psychiatric Association 2012
Submit a response

Comments

No Comments have been published for this article.